Erstellt von fchar99
Hasbro Inc. diskutieren
Hasbro Inc.
WKN: 859888 / Symbol: HAS / Name: Hasbro / Aktie / Freizeitprodukte / Large Cap /
58,80 €
3,46 %
Hasbro, Inc. (NASDAQ: HAS) had its price target raised by analysts at Stifel Nicolaus from $64.00 to $67.00. They now have a "buy" rating on the stock.
Ratings data for HAS provided by MarketBeat
Hasbro, Inc. (NASDAQ: HAS) had its price target raised by analysts at Monness Crespi & Hardt from $60.00 to $75.00. They now have a "buy" rating on the stock.
Ratings data for HAS provided by MarketBeat
Hasbro, Inc. (NASDAQ: HAS) had its price target raised by analysts at Roth Mkm from $65.00 to $75.00. They now have a "buy" rating on the stock.
Ratings data for HAS provided by MarketBeat
Hasbro, Inc. (NASDAQ: HAS) had its "overweight" rating re-affirmed by analysts at Morgan Stanley. They now have a $77.00 price target on the stock.
Ratings data for HAS provided by MarketBeat
Hasbro, Inc. (NASDAQ: HAS) was upgraded by analysts at JPMorgan Chase & Co. from a "neutral" rating to an "overweight" rating. They now have a $74.00 price target on the stock, up previously from $61.00.
Ratings data for HAS provided by MarketBeat
Hasbro, Inc. (NASDAQ: HAS) had its price target raised by analysts at UBS Group AG from $68.00 to $69.00. They now have a "buy" rating on the stock.
Ratings data for HAS provided by MarketBeat
Hasbro, Inc. (NASDAQ: HAS) was upgraded by analysts at Bank of America Co. from a "neutral" rating to a "buy" rating. They now have a $80.00 price target on the stock, up previously from $70.00.
Ratings data for HAS provided by MarketBeat
Hasbro, Inc. (NASDAQ: HAS) had its price target raised by analysts at Stifel Nicolaus from $76.00 to $78.00. They now have a "buy" rating on the stock.
Ratings data for HAS provided by MarketBeat
Hasbro, Inc. (NASDAQ: HAS) had its price target raised by analysts at Morgan Stanley from $78.00 to $79.00. They now have an "overweight" rating on the stock.
Ratings data for HAS provided by MarketBeat
Neueste Beiträge
Needham___Company_LL in Biogen Inc. diskutieren